{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:04:58Z","timestamp":1784275498062,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06242-w","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:15:02Z","timestamp":1783523702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anakinra for recurrent pericarditis: a retrospective evaluation of long-term effectiveness, initiation timing and tapering"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-154X","authenticated-orcid":false,"given":"Elpida","family":"Skouvaklidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4577-2324","authenticated-orcid":false,"given":"Maria","family":"Boutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-6851","authenticated-orcid":false,"given":"Christina","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-9760","authenticated-orcid":false,"given":"Efstratios","family":"Gavriilidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-5286","authenticated-orcid":false,"given":"Stergios","family":"Soulaidopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-6319","authenticated-orcid":false,"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1514-3618","authenticated-orcid":false,"given":"Maria G.","family":"Mytilinaiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-7015","authenticated-orcid":false,"given":"Panagiotis","family":"Skendros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-496X","authenticated-orcid":false,"given":"Charalampos","family":"Papagoras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"6242_CR1","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1002\/ehf2.15231","volume":"12","author":"M Merlo","year":"2025","unstructured":"Merlo M, Bassetto G, Cannat\u00e0 A, Aimo A, Autore C, Bauce B et al (2025) Inflammation and Genetics in Myo-Pericardial Diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases. ESC Heart Fail 12:3987\u20133999. https:\/\/doi.org\/10.1002\/ehf2.15231","journal-title":"ESC Heart Fail"},{"key":"6242_CR2","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J, Adler Y, Brucato A, Christian V et al (2025) 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J 46:3952\u20134041. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf192","journal-title":"Eur Heart J"},{"key":"6242_CR3","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s10067-023-06656-y","volume":"42","author":"O Zimba","year":"2023","unstructured":"Zimba O, Gasparyan AY (2023) Cardiovascular issues in rheumatic diseases. Clin Rheumatol 42:2535\u20132539. https:\/\/doi.org\/10.1007\/s10067-023-06656-y","journal-title":"Clin Rheumatol"},{"key":"6242_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.120.051156","volume":"143","author":"M Imazio","year":"2021","unstructured":"Imazio M, Pivetta E, Andreis A, Serra C, Carbone F, Masoero M et al (2021) Incessant Pericarditis as a Risk Factor for Complicated Pericarditis and Hospital Admission. Circulation 143:401\u2013402. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051156","journal-title":"Circulation"},{"key":"6242_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024931","author":"CJ Peet","year":"2022","unstructured":"Peet CJ, Rowczenio D, Omoyinmi E, Papadopoulou C, Mapalo BRR, Wood MR et al (2022) Pericarditis and autoinflammation: a clinical and genetic analysis of patients with idiopathic recurrent pericarditis and monogenic autoinflammatory diseases at a national referral center. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.121.024931","journal-title":"J Am Heart Assoc"},{"key":"6242_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/S00296-017-3853-8","volume":"38","author":"E Erken","year":"2018","unstructured":"Erken E, Erken E (2018) Cardiac disease in familial Mediterranean fever. Rheumatol Int 38:51\u201358. https:\/\/doi.org\/10.1007\/S00296-017-3853-8","journal-title":"Rheumatol Int"},{"key":"6242_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/S00296-017-3854-7","volume":"38","author":"R Hintenberger","year":"2018","unstructured":"Hintenberger R, Falkinger A, Danninger K, Pieringer H (2018) Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 38:37\u201350. https:\/\/doi.org\/10.1007\/S00296-017-3854-7","journal-title":"Rheumatol Int"},{"key":"6242_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/ART.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879\u20131885. https:\/\/doi.org\/10.1002\/ART.1780401023","journal-title":"Arthritis Rheum"},{"key":"6242_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/ph17081069","volume":"17","author":"E Lazarou","year":"2024","unstructured":"Lazarou E, Koutsianas C, Vlachakis PK, Theofilis P, Vassilopoulos D, Tsioufis C et al (2024) Novel Treatments in Refractory Recurrent Pericarditis. Pharmaceuticals 17:1069. https:\/\/doi.org\/10.3390\/ph17081069","journal-title":"Pharmaceuticals"},{"key":"6242_CR10","doi-asserted-by":"publisher","first-page":"21685","DOI":"10.1161\/JAHA.121.021685","volume":"10","author":"S Lo Presti","year":"2021","unstructured":"Lo Presti S, Elajami TK, Reyaldeen R, Anthony C, Imazio M, Klein AL (2021) Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors. J Am Heart Assoc 10:21685. https:\/\/doi.org\/10.1161\/JAHA.121.021685","journal-title":"J Am Heart Assoc"},{"key":"6242_CR11","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","volume":"316","author":"A Brucato","year":"2016","unstructured":"Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M et al (2016) Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence. JAMA 316:1906. https:\/\/doi.org\/10.1001\/jama.2016.15826","journal-title":"JAMA"},{"key":"6242_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/2047487319879534","volume":"27","author":"M Imazio","year":"2020","unstructured":"Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S et al (2020) Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study. Eur J Prev Cardiol 27:956\u2013964. https:\/\/doi.org\/10.1177\/2047487319879534","journal-title":"Eur J Prev Cardiol"},{"key":"6242_CR13","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1136\/annrheumdis-2014-205990","volume":"73","author":"G Lazaros","year":"2014","unstructured":"Lazaros G, Vasileiou P, Koutsianas C, Antonatou K, Stefanadis C, Pectasides D et al (2014) Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis 73:2215\u20132217. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205990","journal-title":"Ann Rheum Dis"},{"key":"6242_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa2027892","volume":"384","author":"AL Klein","year":"2021","unstructured":"Klein AL, Imazio M, Cremer P, Brucato A, Abbate A, Fang F et al (2021) Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med 384:31\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2027892","journal-title":"N Engl J Med"},{"key":"6242_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/rheumatology\/key077","volume":"57","author":"N Kougkas","year":"2018","unstructured":"Kougkas N, Fanouriakis A, Papalopoulos I, Bertsias G, Avgoustidis N, Repa A et al (2018) Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. Rheumatology 57:1494\u20131495. https:\/\/doi.org\/10.1093\/rheumatology\/key077","journal-title":"Rheumatology"},{"key":"6242_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jacc.2023.04.046","volume":"82","author":"AL Myachikova VYu, Maslyanskiy","year":"2023","unstructured":"Myachikova VYu, Maslyanskiy AL, Moiseeva OM, Vinogradova OV, Gleykina EV, Lavrovsky Y et al (2023) Treatment of Idiopathic Recurrent Pericarditis With Goflikicept. J Am Coll Cardiol 82:30\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2023.04.046","journal-title":"J Am Coll Cardiol"},{"key":"6242_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/annrheumdis-2014-205202","volume":"75","author":"J Z\u00e1vada","year":"2016","unstructured":"Z\u00e1vada J, Uher M, Sisol K, Forejtov\u00e1 \u0160, Jaro\u0161ov\u00e1 K, Mann H et al (2016) A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1\u2005year: a propensity score-matched cohort study. Ann Rheum Dis 75:96\u2013102. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205202","journal-title":"Ann Rheum Dis"},{"key":"6242_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00393-023-01471-x","volume":"83","author":"Z Toker Dincer","year":"2024","unstructured":"Toker Dincer Z, Karup S, Yilmaz E, Corbali O, Azman FN, Melikoglu M et al (2024) Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review. Z Rheumatol 83:587\u2013596. https:\/\/doi.org\/10.1007\/s00393-023-01471-x","journal-title":"Z Rheumatol"},{"key":"6242_CR19","doi-asserted-by":"publisher","first-page":"133204","DOI":"10.1016\/j.ijcard.2025.133204","volume":"430","author":"M Michaud","year":"2025","unstructured":"Michaud M, Sailler L, Lemeu M, Castel B, Vacheret F, Prudhomme L et al (2025) Efficacy and safety of Anakinra in idiopathic recurrent pericarditis: Results from the UPACITER study. Int J Cardiol 430:133204. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133204","journal-title":"Int J Cardiol"},{"key":"6242_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.amjcard.2015.07.047","volume":"116","author":"S Jain","year":"2015","unstructured":"Jain S, Thongprayoon C, Espinosa RE, Hayes SN, Klarich KW, Cooper LT et al (2015) Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis. Am J Cardiol 116:1277\u20131279. https:\/\/doi.org\/10.1016\/j.amjcard.2015.07.047","journal-title":"Am J Cardiol"},{"key":"6242_CR21","doi-asserted-by":"publisher","unstructured":"Lazarou E, Koutsianas C, Theofilis P, Lazaros G, Vassilopoulos D, Vlachopoulos C et al (2024) Interleukin-1 blockers: a paradigm shift in the treatment of recurrent pericarditis. 14:305. https:\/\/doi.org\/10.3390\/life14030305","DOI":"10.3390\/life14030305"},{"key":"6242_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2020.03.069","volume":"311","author":"G Lazaros","year":"2020","unstructured":"Lazaros G, Antonopoulos AS, Antonatou K, Skendros P, Ritis K, Hadziyannis E et al (2020) Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. Int J Cardiol 311:77\u201382. https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.069","journal-title":"Int J Cardiol"},{"key":"6242_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejim.2025.03.016","volume":"138","author":"D Sagris","year":"2025","unstructured":"Sagris D, Antoniadou C, Gatselis NK, Gavriilidis E, Papadopoulos V, Georgiadou S et al (2025) R202Q homozygosity of Mediterranean fever gene is associated with atypical clinical phenotype of familial Mediterranean fever. Eur J Intern Med 138:69\u201375. https:\/\/doi.org\/10.1016\/j.ejim.2025.03.016","journal-title":"Eur J Intern Med"},{"key":"6242_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2459\/JCM.0000000000001669","volume":"25","author":"M Imazio","year":"2024","unstructured":"Imazio M, Faletra F, Zucco J, Mio C, Carraro M, Gava AM et al (2024) Genetic variants in patients with recurrent pericarditis. J Cardiovasc Med 25:799\u2013804. https:\/\/doi.org\/10.2459\/JCM.0000000000001669","journal-title":"J Cardiovasc Med"},{"key":"6242_CR25","doi-asserted-by":"publisher","first-page":"1483669","DOI":"10.3389\/FPHAR.2025.1483669","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Yan W, Li J, Yan D, Luo D (2025) Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system. Front Pharmacol 16:1483669. https:\/\/doi.org\/10.3389\/FPHAR.2025.1483669","journal-title":"Front Pharmacol"},{"key":"6242_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107405","author":"E Kyriazopoulou","year":"2024","unstructured":"Kyriazopoulou E, Akinosoglou K, Florou E, Kouriannidi E, Bogosian A, Tsachouridou O et al (2024) Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: association with the inflammatory burden of the host. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107405","journal-title":"Int J Antimicrob Agents"},{"key":"6242_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101573","author":"G Tavoulareas","year":"2026","unstructured":"Tavoulareas G, Kontakou-Zoniou O, Antonakos N, Tasouli E, Adamis G, Kakavoulis N et al (2026) Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial. Lancet Reg Health - Europe. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101573","journal-title":"Lancet Reg Health - Europe"},{"key":"6242_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/EJH.14029","volume":"111","author":"JEG Charlesworth","year":"2023","unstructured":"Charlesworth JEG, Kavirayani A (2023) Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis\/macrophage activation syndrome: A systematic review. Eur J Haematol 111:458\u2013476. https:\/\/doi.org\/10.1111\/EJH.14029","journal-title":"Eur J Haematol"},{"key":"6242_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/heartjnl-2020-316898","volume":"106","author":"A Andreis","year":"2020","unstructured":"Andreis A, Imazio M, Giustetto C, Brucato A, Adler Y, De Ferrari GM (2020) Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis. Heart 106:1561\u20131565. https:\/\/doi.org\/10.1136\/heartjnl-2020-316898","journal-title":"Heart"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06242-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:16:54Z","timestamp":1784272614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06242-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6242"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06242-w","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial Intelligence was not used either for drafting or editing this article.","order":2,"name":"Ethics","label":"Artificial intelligence use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A related abstract was published in EULAR 2026 congress in Poster View III (Poster View) session. Citation: volume 85, supplement 1, year 2026, page s897. DOI: annrheumdis-2026-eular.B.1735.","order":3,"name":"Ethics","label":"Congress abstract publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No part of this report is copied, published elsewhere, or generated by artificial intelligence.","order":4,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"194"}}